These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Longitudinal study of multi-parameter quantitative magnetic resonance imaging in Duchenne muscular dystrophy: hyperresponsiveness of gluteus maximus and detection of subclinical disease progression in functionally stable patients. Peng F; Xu H; Song Y; Xu K; Li S; Cai X; Guo Y; Gong L J Neurol; 2023 Mar; 270(3):1439-1451. PubMed ID: 36385201 [TBL] [Abstract][Full Text] [Related]
14. Quantitative muscle ultrasound in children with Duchenne muscular dystrophy: Comparing to magnetic resonance imaging. Hu J; Jiang L; Hong S; Cheng L; Wang Q; Peng X; Qin J; Zou L J Clin Ultrasound; 2023 May; 51(4):674-679. PubMed ID: 36449321 [TBL] [Abstract][Full Text] [Related]
15. Sensitive ultrasonic detection of dystrophic skeletal muscle in patients with duchenne muscular dystrophy using an entropy-based signal receiver. Hughes MS; Marsh JN; Wallace KD; Donahue TA; Connolly AM; Lanza GM; Wickline SA Ultrasound Med Biol; 2007 Aug; 33(8):1236-43. PubMed ID: 17467153 [TBL] [Abstract][Full Text] [Related]
16. Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy. Guo LJ; Soslow JH; Bettis AK; Nghiem PP; Cummings KJ; Lenox MW; Miller MW; Kornegay JN; Spurney CF J Am Heart Assoc; 2019 Aug; 8(16):e012443. PubMed ID: 31411085 [TBL] [Abstract][Full Text] [Related]
17. Lower Extremity Muscle Involvement in the Intermediate and Bethlem Myopathy Forms of COL6-Related Dystrophy and Duchenne Muscular Dystrophy: A Cross-Sectional Study. Batra A; Lott DJ; Willcocks R; Forbes SC; Triplett W; Dastgir J; Yun P; Reghan Foley A; Bönnemann CG; Vandenborne K; Walter GA J Neuromuscul Dis; 2020; 7(4):407-417. PubMed ID: 32538860 [TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy. Barnard AM; Willcocks RJ; Finanger EL; Daniels MJ; Triplett WT; Rooney WD; Lott DJ; Forbes SC; Wang DJ; Senesac CR; Harrington AT; Finkel RS; Russman BS; Byrne BJ; Tennekoon GI; Walter GA; Sweeney HL; Vandenborne K PLoS One; 2018; 13(3):e0194283. PubMed ID: 29554116 [TBL] [Abstract][Full Text] [Related]
19. Oedema-fibrosis in Duchenne Muscular Dystrophy: Role of cardiovascular magnetic resonance imaging. Mavrogeni S; Papavasiliou A; Giannakopoulou K; Markousis-Mavrogenis G; Pons MR; Karanasios E; Nikas I; Papadopoulos G; Kolovou G; Chrousos GP Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 29027210 [TBL] [Abstract][Full Text] [Related]
20. Utilization of T1-Mapping for the pelvic and thigh muscles in Duchenne Muscular Dystrophy: a quantitative biomarker for disease involvement and correlation with clinical assessments. Peng F; Xu H; Song Y; Xu K; Li S; Cai X; Guo Y; Gong L BMC Musculoskelet Disord; 2022 Jul; 23(1):681. PubMed ID: 35842609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]